<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">18780165</PMID>
        <DateCompleted>
            <Year>2009</Year>
            <Month>05</Month>
            <Day>11</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1573-2592</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>29</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2009</Year>
                        <Month>Mar</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of clinical immunology</Title>
                <ISOAbbreviation>J. Clin. Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>HLA class II (DRB, DQA1 and DQB1) allele and haplotype frequencies in the patients with pemphigus vulgaris.</ArticleTitle>
            <Pagination>
                <MedlinePgn>175-9</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10875-008-9244-x</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Pemphigus vulgaris (PV), an autoimmune disease affecting the skin and mucous membranes, is associated with some human leukocyte antigen (HLA) class II alleles and haplotypes.</AbstractText>
                <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">In order to evaluate the association of HLA-DR and DQ alleles and haplotypes in Iranian non-Jewish patients with PV, 52 patients with PV and 180 normal subjects as control group were investigated in this study.</AbstractText>
                <AbstractText Label="RESULTS AND DISCUSSION" NlmCategory="CONCLUSIONS">HLA-DRB1*04, -DRB1*1401, -DRB4, -DQA1*0104, -DQA1*03011, -DQB1*0302, and -DQB1*0502 alleles have been significantly increased in our patients group. Moreover, the haplotypes HLA-DRB1*04/-DQA1*03011/-DQB1*0302 and HLA-DRB1*1401/-DQA1*0104/-DQB1*0502 increased significantly in our patients. In contrast, the following alleles decreased significantly in our patients: HLA-DRB1*15, -DRB1*0301, -DRB1*07, -DRB1*11, -DRB5, -DQA1*0101, -DQA1*0103, -DQA1*201, -DQA1*05, -DQB1*0201, -DQB1*0301, -DQB1*06011, and -DQB1*0602. In addition, HLA-DRB1*15/-DQA1*0103/-DQB1*06011, HLA-DRB1*0301/-DQA1*05011/-DQB1*0201, HLA-DRB1*07/-DQA1*0201/-DQB1*0201, and HLA-DRB1*11/-DQA1*05/-DQB1*03011 decreased significantly in our patients. Genetic factors are involved in the occurrence of PV; HLA-DRB1*04 and -DRB1*1401 alleles and the related haplotypes are suggestive to be two major PV susceptibility factors in our population study.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Shams</LastName>
                    <ForeName>Sheida</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology, Razi Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Amirzargar</LastName>
                    <ForeName>Ali Akbar</ForeName>
                    <Initials>AA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yousefi</LastName>
                    <ForeName>Maryam</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rezaei</LastName>
                    <ForeName>Nima</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Solgi</LastName>
                    <ForeName>Ghasem</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Khosravi</LastName>
                    <ForeName>Farideh</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ansaripour</LastName>
                    <ForeName>Bita</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moradi</LastName>
                    <ForeName>Batoul</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nikbin</LastName>
                    <ForeName>Behrouz</ForeName>
                    <Initials>B</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2008</Year>
                <Month>09</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>J Clin Immunol</MedlineTA>
            <NlmUniqueID>8102137</NlmUniqueID>
            <ISSNLinking>0271-9142</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006683">HLA-DQ Antigens</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D059848">HLA-DQ alpha-Chains</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D059866">HLA-DQ beta-Chains</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C069050">HLA-DQA1 antigen</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C069051">HLA-DQB1 antigen</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006684">HLA-DR Antigens</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D059811">HLA-DRB1 Chains</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C553502">HLA-DRB1*03:01 antigen</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006683" MajorTopicYN="N">HLA-DQ Antigens</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059848" MajorTopicYN="N">HLA-DQ alpha-Chains</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059866" MajorTopicYN="N">HLA-DQ beta-Chains</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006684" MajorTopicYN="N">HLA-DR Antigens</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059811" MajorTopicYN="N">HLA-DRB1 Chains</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010392" MajorTopicYN="N">Pemphigus</DescriptorName>
                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2008</Year>
                <Month>07</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2008</Year>
                <Month>08</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2008</Year>
                <Month>9</Month>
                <Day>10</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2009</Year>
                <Month>5</Month>
                <Day>12</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2008</Year>
                <Month>9</Month>
                <Day>10</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">18780165</ArticleId>
            <ArticleId IdType="doi">10.1007/s10875-008-9244-x</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Oral Dis. 2005 May;11(3):119-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15888101</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Immunol. 2003 Aug;64(8):771-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12878355</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Autoimmunity. 1999;30(3):183-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10520901</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11935-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8524878</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Autoimmun Rev. 2005 Jan;4(1):16-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15652774</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tissue Antigens. 2004 Apr;63(4):326-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15009804</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 1997 Jan 1;99(1):31-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9011573</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Dermatol. 1996 Mar;21(2):100-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8759194</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Dermatol. 2005 Jun;44(6):470-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15941433</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Autoimmun Rev. 2003 Sep;2(5):278-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12965179</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cutan Med Surg. 2002 Sep-Oct;6(5):422-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12196893</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Dermatol. 2002 Feb;41(2):79-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11982641</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Immunol. 1997 Sep 15;57(1):62-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9438197</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tissue Antigens. 1992 May;39(5):225-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1357775</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tissue Antigens. 1999 Oct;54(4):333-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10551416</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Immunol. 1997 Oct;57(2):110-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9438202</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1988 May;85(10):3504-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3368460</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):5056-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1675792</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Autoimmun. 2005 Jun;24(4):319-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15869862</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Autoimmun. 2000 Aug;15(1):67-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10936030</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chin Med Sci J. 2005 Sep;20(3):166-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16261886</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1989 Aug;86(16):6215-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2503828</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Exp Med. 1993 Feb 1;177(2):419-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8426112</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2003 Jan 1;170(1):635-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12496453</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Immunol. 2001 Nov;62(11):1234-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11704285</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Tuberc Lung Dis. 2004 Aug;8(8):1017-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15305487</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>